ARS Pharmaceuticals, Inc. Taxes Payable, Current
ARS Pharmaceuticals, Inc. (SPRY) had Taxes Payable, Current of $13.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-06.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:TaxesPayableCurrent · last filed 2024-08-06
- 2024-06-30: Taxes Payable, Current $13.00K.
- 2024-03-31: Taxes Payable, Current $47.00K.
- 2023-12-31: Taxes Payable, Current $4.00K.
- 2023-09-30: Taxes Payable, Current $0.00.
| Period end | Taxes Payable, Current |
|---|---|
| 2024-06-30 | $13.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $47.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $4.00K 10-Q · filed 2024-08-06 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 |
| 2023-06-30 | $82.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $187.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $174.00K 10-K · filed 2024-03-21 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |